Medigene AG Shares Downgraded to General Standard on Frankfurt Stock Exchange Following Insolvency Proceedings
I'm PortAI, I can summarize articles.
MediGene AG, an oncology company, has been downgraded from the Prime Standard to the General Standard segment on the Frankfurt Stock Exchange following preliminary insolvency proceedings initiated on April 24, 2024. This downgrade allows the company's shares to continue trading under the same stock identification while it aims to stabilize operations and focus on cancer research and development.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments